SYS ONLINE
SUPPLEMENT_SCHOLAR
evidence · mechanism · dose
Experimental/GH SecretagogueResearch peptide

GHRP-6

First-generation ghrelin mimetic that produces a strong appetite signal alongside GH release.

Educational explainer of a research peptide. Profiles in this section deliberately omit clinical-trial citations, dosing protocols, and purchase links. Not FDA-approved as a supplement; not a recommendation to use.

Overview

GHRP-6 is a synthetic hexapeptide that activates the ghrelin receptor, releasing GH and producing a pronounced hunger response.

Source
  • Synthesized in research laboratories
Forms
  • Subcutaneous injection

Mechanism of action

Binds GHS-R1a in the pituitary for GH release and in hypothalamic NPY/AgRP neurons to trigger appetite.

Pathways
  • · GHS-R1a
  • · NPY/AgRP appetite circuit
Receptors
  • · GHS-R1a
Hormones
  • · GH
  • · IGF-1
  • · Cortisol

How it acts on the body

GHRP-6 is the prototypical ghrelin mimetic and the first of its class characterized in detail. The receptor that pulses GH from the pituitary is also expressed on NPY/AgRP hunger neurons, which is why injection produces a noticeable appetite spike within minutes.

Compared with GHRP-2, the GH pulse is similar but appetite, cortisol, and prolactin responses are stronger. That makes it a poor first choice for fat-loss or insulin-sensitivity goals, but historically interesting in cachexia and post-injury anorexia where stimulating hunger is the point.

Hormonal & endocrine impact

How this peptide is reported to shift specific hormones and signaling molecules. Directionality reflects research literature and preclinical models, not clinical prescribing data.

Projected hormonal trajectory
Illustrative curves derived from reported direction of effect. Not measured patient data.

Curves are schematic shapes (sigmoid for increases/decreases, damped oscillation for modulation/stabilization) anchored to a 100% baseline. They communicate direction and tempo of change reported in research literature — not absolute hormone concentrations.

Growth hormoneIncreases
Robust pulse comparable to other GHRPs.
Ghrelin signalingModulates
Activates GHS-R1a without raising circulating ghrelin.
CortisolIncreases
Acute rise, slightly larger than GHRP-2.
ProlactinIncreases
Modest transient elevation.

Effects on the body

Increases
Appetite
Increases
GH / IGF-1 axis activity
Supports
Recovery in catabolic states

Organ system effects

Endocrine

Pituitary GH release and HPA-axis activation.

Brain & CNS

Strong activation of hunger and reward circuits.

Digestive / Gut

Increases gastric motility via ghrelin receptor.

Reported effects

Drawn from preclinical research, anecdote, and small-scale clinical observation. No evidence grades are assigned — most peptides on this page lack rigorous human trials.

  • Useful in cachexia and appetite-loss research
  • Increased nocturnal GH pulses
  • Improved subjective recovery

Potential side effects

Common
  • · Intense hunger
  • · Water retention
  • · Flushing
Rare
  • · Numbness
  • · Lethargy
Serious
  • · Insulin resistance with chronic high-dose use

Drug interactions

Insulin
Hunger plus altered glucose handling can complicate dosing.
moderate

Pairing context

Often combined with
  • CJC-1295
    GHRH analog amplifies the GH pulse without further raising appetite.
Avoid combining with
  • Active malignancy
    IGF-1 elevation is generally avoided.
Important. Research peptides described here are not FDA-approved supplements. Supplement Scholar does not endorse, recommend, or link to any source for purchase. Consult a qualified clinician before considering any peptide therapy.